EUVIMEDObjevte EUVIMED
EUVIMED · CrossrefJournal

Targeted Oncology

ISSN 1776-2596 · Springer Science and Business Media LLC

Latest articles

  1. Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study

    Pier Luigi Zinzani, David Šálek, Christopher R. Flowers, Fontanet Bijou, Ana C. De Oliveira, Yuqin Song, Qingyuan Zhang, Marco Brociner, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Sam Yuen, Roderick Johnson, Marek Trněný, Rebecca Auer, Alejandro Martín García-Sancho, Mariano Provencio Pulla, Sha Huang, Jiayi Shen, Jamie Hirata, Judith Trotman

    Published: 2026-11-03DOI: 10.1007/s11523-026-01268-3

  2. Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial

    Yu Sunakawa, Hisateru Yasui, Manabu Shiozawa, Hiroyuki Takeda, Naoya Akazawa, Tamotsu Sagawa, Kazuhiro Shiraishi, Takahisa Kyogoku, Takashi Mine, Yasuhiro Yuasa, Takanori Watanabe, Tatsuya Kinjo, Yoshihiro Okita, Hiroyuki Okuyama, Satoshi Yuki, Koki Miyakawa, Ayana Kobara, Shoko Yanaka, Yukiko Abe, Wataru Ichikawa, Masashi Fujii, Akihito Tsuji

    Published: 2026-07DOI: 10.1007/s11523-026-01223-2

  3. From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board

    Tabea Fröhlich, Ulrich Lehmann, Tanja Reineke-Plaaß, Thomas Wirth, Sabrina Welland, Chen Du, Bernd Auber, Benjamin-Alexander Bollmann, Philipp Ivanyi, Tjoung-Won Park-Simon, Diana Steinmann, Christian Hartmann, Ariana de Oliviera Mekonnen, Anja Heutling, Andrea Schütte, Hans Heinrich Wedemeyer, Florian Heinrich Heidel, Susanne Isfort, Arndt Vogel, Anna Saborowski

    Published: 2026-07DOI: 10.1007/s11523-026-01231-2

  4. Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics

    Natalia A. Quijano Cardé, Jin Niu, Yue Guo, Jia Zhou, Xiao Qiu, Yaming Su, Carlos Pérez-Ruixo, Deeksha Vishwamitra, Caroline Hodin, Tara Stephenson, Athena Zuppa, Katherine Chastain, Rachel Kobos, Mahesh N. Samtani, Weirong Wang, Nahor Haddish-Berhane, Niels W. C. J. Van de Donk, Alfred L. Garfall, Jeffrey V. Matous

    Published: 2026-05DOI: 10.1007/s11523-026-01205-4

  5. Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study

    Ligang Xing, Jinming Yu, Xiangjiao Meng, Ren Zhao, Weihua Yang, Yubiao Guo, Juan Li, Min Fan, Chuangying Xiao, Yanping Ren, Lihua Dong, Dongqing Lv, Lujun Zhao, Yingcheng Lin, Xiaotao Zhang, Long Chen, Ye Wang, Yuhui Zhang, Aimin Zang, Gregory Cheng, Anwen Liu, Naixin Liang, Baisong Lou, Jun Wang, Xiaolong Fu, Anhui Shi, Ning Xu, Junfeng Liu, Zuo-Lin Xiang

    Published: 2026-05DOI: 10.1007/s11523-026-01217-0

Volumes

2026 · 842025 · 792024 · 902023 · 862022 · 732021 · 762020 · 812019 · 752018 · 752017 · 772016 · 832015 · 572014 · 422013 · 362012 · 422011 · 292010 · 352009 · 332008 · 332007 · 352006 · 34

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.